Cell factories for methylerythritol phosphate pathway mediated terpenoid biosynthesis: an application of modern engineering towards sustainability

Gaurav Kant,Ashutosh Pandey,Ariba Hasan,Faizal Bux,Sheena Kumari,Sameer Srivastava,Ariba Hassan
DOI: https://doi.org/10.1016/j.procbio.2024.01.027
IF: 4.885
2024-02-07
Process Biochemistry
Abstract:Terpenoids and their derivatives which are synthesized either through the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways represent a most diversified class of natural compounds with a wide range of therapeutic properties such as anticancer, antimicrobial, antiparasitic, and antiallergenic. Globally, terpenoids are in high demand due to their excellent pharmaceutical applications and their potential benefits in many sectors. However, since these compounds are present in small quantities in nature, their use on a large scale is limited. Moreover, the petroleum-based production of these compounds is managing the current market demand worldwide. Nevertheless, the increase in greenhouse gas emissions and global warming makes the above approach unsustainable for commercial scale production. This can be addressed by metabolic pathway engineering, a promising method of synthetic biology that enables the efficient modification of microbial pathways to produce high value compounds on a continuous and sustainable basis. In this review, we primarily focus on the importance and utility of MEP pathway for the biosynthesis of targeted terpenoids. Different type of terpenoids, their commercial applications, and engineering initiatives to increase the titers of valuable terpenoids from cell factories are also discussed.
biochemistry & molecular biology,biotechnology & applied microbiology,engineering, chemical
What problem does this paper attempt to address?